GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Aveo Healthcare Ltd (ASX:AEH) » Definitions » Research & Development

Aveo Healthcare (ASX:AEH) Research & Development : A$0.00 Mil (TTM As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Aveo Healthcare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aveo Healthcare's Research & Development for the six months ended in Dec. 2013 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 was A$0.00 Mil.


Aveo Healthcare Research & Development Historical Data

The historical data trend for Aveo Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveo Healthcare Research & Development Chart

Aveo Healthcare Annual Data
Trend Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aveo Healthcare Semi-Annual Data
Jun04 Dec04 Jun05 Dec05 Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aveo Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aveo Healthcare  (ASX:AEH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Aveo Healthcare Research & Development Related Terms

Thank you for viewing the detailed overview of Aveo Healthcare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveo Healthcare (ASX:AEH) Business Description

Traded in Other Exchanges
N/A
Address
Aveo Healthcare Ltd provides retirement communities in South-East Queensland. The Company's healthcare's portfolio comprises five retirement villages, located in Albany Creet, Clayfield, Cleveland, Durack and Taringa.

Aveo Healthcare (ASX:AEH) Headlines

From GuruFocus

A Trio of Low Price-Book Ratio Stocks

By Alberto Abaterusso 10-14-2021

Maarten Edixhoven to leave Aegon the Netherlands

By Business Wire Business Wire 05-11-2021

Allegra van H�vell-Patrizi appointed CEO of Aegon the Netherlands

By Business Wire Business Wire 06-15-2021

Aegon's Global Chief Technology Officer Mark Bloom to step down

By Business Wire Business Wire 04-20-2021

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 05-26-2022

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 06-15-2022

Aegon AM adds three to Responsible Investment team

By PRNewswire PRNewswire 10-13-2021

Aegon appoints Will Fuller as President and CEO of Transamerica

By Business Wire Business Wire 03-11-2021